Safety and Efficacy of DCB Therapy for de Novo Lesions Under the Guidance of QFR in CHD Patients (UNIQUE-DCB-I Study )

Clinical trial NCT04104854 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04104854
Sponsor: Nanjing First Hospital, Nanjing Medical University
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronary Heart Disease

Start date: 2026-01-01
Primary completion: 2028-12-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.